title: Rituximab and Fcγ Receptors in Granulomatosis With Polyangiitis (Wegener's): Comment on the Article by Cartin-Ceba et al.
authors.affiliation: University Hospital of Heidelberg, Heidelberg, Germany and Leibniz Research Center for Working Environment and Human Factors at TU Dortmund, Dortmund, Germany.
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Merkt
authors.affiliation: University Hospital of Heidelberg, Heidelberg, Germany.
authors.forename: Hanns-Martin
authors.initials: HM
authors.lastname: Lorenz
authors.affiliation: Leibniz Research Center for Working Environment and Human Factors at TU Dortmund, Dortmund, Germany.
authors.forename: Carsten
authors.initials: C
authors.lastname: Watzl
mesh_terms: D019268:Antibodies, Antineutrophil Cytoplasmic; D003520:Cyclophosphamide; D003577:Cytochrome P-450 Enzyme System; D014890:Granulomatosis with Polyangiitis; D006801:Humans; D010597:Pharmacogenetics; D017452:Receptors, IgG; D000069283:Rituximab
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D017452:Receptors, IgG; D000069283:Rituximab; D003520:Cyclophosphamide; D003577:Cytochrome P-450 Enzyme System